Insulin-deficient diabetes-induced bone microarchitecture alterations are associated with a decrease in the osteogenic potential of bone marrow progenitor cells: preventive effects of metformin

cic.institucionOrigenLaboratorio de Investigación en Osteopatías y Metabolismo Minerales
cic.isFulltexttruees
cic.isPeerReviewedtruees
cic.lugarDesarrolloLaboratorio de Investigación en Osteopatías y Metabolismo Minerales
cic.versioninfo:eu-repo/semantics/publishedVersiones
dc.date.accessioned2021-10-07T17:40:58Z
dc.date.available2021-10-07T17:40:58Z
dc.identifier.urihttps://digital.cic.gba.gob.ar/handle/11746/11321
dc.titleInsulin-deficient diabetes-induced bone microarchitecture alterations are associated with a decrease in the osteogenic potential of bone marrow progenitor cells: preventive effects of metforminen
dc.typeArtículoes
dcterms.abstractAims: Diabetes mellitus is associated with metabolic bone disease and increased lowimpact fractures. The insulin-sensitizer metformin possesses in vitro, in vivo and ex vivo osteogenic effects, although this has not been adequately studied in the context of diabetes. We evaluated the effect of insulin-deficient diabetes and/or metformin on bone microarchitecture, on osteogenic potential of bone marrow progenitor cells (BMPC) and possible mechanisms involved. Methods: Partially insulin-deficient diabetes was induced in rats by nicotinamide/streptozotocin- injection, with or without oral metformin treatment. Femoral metaphysis microarchitecture, ex vivo osteogenic potential of BMPC, and BMPC expression of Runx-2, PPARg and receptor for advanced glycation endproducts (RAGE) were investigated. Results: Histomorphometric analysis of diabetic femoral metaphysis demonstrated a slight decrease in trabecular area and a significant reduction in osteocyte density, growth plate height and TRAP (tartrate-resistant acid phosphatase) activity in the primary spongiosa. BMPC obtained from diabetic animals showed a reduction in Runx-2/PPARg ratio and in their osteogenic potential, and an increase in RAGE expression. Metformin treatment prevented the diabetes-induced alterations in bone micro-architecture and BMPC osteogenic potential. Conclusion: Partially insulin-deficient diabetes induces deleterious effects on long-bone micro-architecture that are associated with a decrease in BMPC osteogenic potential, which could be mediated by a decrease in their Runx-2/PPARg ratio and up-regulation of RAGE. These diabetes-induced alterations can be totally or partially prevented by oral administration of metformin.en
dcterms.creator.authorTolosa, María Josées
dcterms.creator.authorChuguransky, Sara Rocíoes
dcterms.creator.authorSedlinsky, Claudiaes
dcterms.creator.authorSchurman, Leónes
dcterms.creator.authorMcCarthy, Antonio Desmondes
dcterms.creator.authorMolinuevo, María Silvinaes
dcterms.creator.authorCortizo, Ana Maríaes
dcterms.extent177-186es
dcterms.identifier.otherdoi:10.1016/j.diabres.2013.05.016es
dcterms.identifier.otherISSN:0168-8227es
dcterms.isPartOf.issuevol. 101, no. 2es
dcterms.isPartOf.seriesDiabetes Research and Clinical Practicees
dcterms.issued2013
dcterms.languageIngléses
dcterms.licenseAttribution-NonCommercial-ShareAlike 4.0 International (BY-NC-SA 4.0)es
dcterms.subjectDiabetes Mellitusen
dcterms.subjectMetforminen
dcterms.subjectBone microarchitectureen
dcterms.subjectBone marrow progenitor cellsen
dcterms.subject.materiaCiencias Médicases

Archivos

Bloque original
Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
2013_Tolosa MJ_Diabetes Res Clin Pract.pdf-PDFA.pdf
Tamaño:
1.7 MB
Formato:
Adobe Portable Document Format
Descripción:
Documento completo